PainReform Ltd. develops reformulations of established pain therapeutics. Its PRF-110 product is a viscous clear oil-based solution instilled directly into surgical wounds to provide localized and extended post-operative analgesia. PRF-110 is in clinical trials related to bunionectomy surgeries and hernia repairs. PainReform was incorporated in 2007 and is headquartered in Tel Aviv, Israel.
What is Painreform's quote symbol?
What is the 52 week high and low for Painreform (NASDAQ: PRFX)?
How much is Painreform stock worth today?
How much is Painreform's stock price per share?
What is Painreform's Market Cap?